UBS Group
DVAX

UBS Group’s Dynavax Technologies DVAX Stock Holding History

UBS Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-77,800
Closed -$816K – 7815
2016
Q3 		$816K Buy
+77,800
New +$1.12M ﹤0.01% 3563

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's DVAX Position: Q1 2026 in Review

UBS Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 260,511 shares — an estimated $4.01M sold.

UBS Group first reported a position in DVAX in Q4 2014 and held it in 45 quarters. The position peaked at $9.06M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • UBS Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 260,511 Dynavax Technologies shares in Q1 2026, an estimated $4.01M.
  • UBS Group first reported a position in Dynavax Technologies in Q4 2014 and held it in 45 quarters.
  • UBS Group's Dynavax Technologies position peaked at $9.06M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.